Researchers have developed nasal drops that travel along the nerves of the nose into the central nervous system to fight the deadliest brain cancer.
Preliminary test results reveal that the medication safely reached its target, helping protect mice against these usually fatal tumors.
"This is an approach that offers hope for safer, more effective treatments for glioblastoma and potentially other immune treatment-resistant cancers, and it marks a critical step toward clinical application," says neurosurgeon Alexander Stegh of Washington University.
"This redefines how cancer immunotherapy ca